The JSE will investigate Aspen Pharmacare Holdings after shares in the continent’s largest generic drugmaker fell the most in five years after a conference call it hosted.
[link url=http://www.bloomberg.com/news/2014-06-30/aspen-investor-to-send-jse-formal-complaint-following-stock-drop.html]Full Bloomberg report[/link]